Moreover, evaluation of the prognostic value of MEN1 expression in the 1643 primary tumor samples has shown that MEN1 expression is independently associated with worse biochemical relapse-free survival (BRFS) and overall survival (OS) (Fig. 2G, H and Table S6). Here, MEN1 is linked to neoplasm.